Rasagiline 1 mg capsule

DRUG3 trials

Sponsors

Merck Sharp & Dohme LLC, New York Medical College

Conditions

PARKINSON DISEASE (Disorder)Parkinson Disease

Phase 3

A Placebo- and Active Controlled Study of Preladenant in Subjects With Moderate to Severe Parkinson's Disease (P04938)

CompletedNCT01155466

Merck Sharp & Dohme LLCParkinson Disease

Start: 2010-07-14End: 2012-12-20Updated: 2018-11-06

A Placebo- and Active-Controlled Study of Preladenant in Early Parkinson's Disease (PD) (P05664)

TerminatedNCT01155479

Merck Sharp & Dohme LLCParkinson Disease

Start: 2010-07-06End: 2013-07-16Updated: 2018-11-07

Phase 4

Effect of Rasagiline on Balance in Parkinson's Disease as Measured by Computerized Posturography

WithdrawnNCT07077187

New York Medical CollegePARKINSON DISEASE (Disorder)

Start: 2014-09-15End: 2017-07-10Updated: 2025-07-24

Related Papers

Randomized trial of preladenant, given as monotherapy, in patients with early Parkinson disease.

2017-05-1044 citations

Preladenant as an Adjunctive Therapy With Levodopa in Parkinson Disease

JAMA Neurology2015-11-0290 citations